Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-AKT1S1 Antibody (R2T04)

Catalog #:   RHN89401 Specific References (14) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IP, WB
Accession: Q96B36
Overview

Catalog No.

RHN89401

Species reactivity

Human, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Applications

IP, WB

Recommended Dilution

Application Dilution
IP 1:20, WB: 1:500-1:1000

Target

Proline-rich AKT1 substrate 1, 40 kDa proline-rich AKT substrate, PRAS40, AKT1S1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q96B36

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2T04

Note

For research use only.

Data Image
  • Western blot
    Western blot analysis of PRAS40 in Hela, A549, C6 lysates using PRAS40 antibody.
References

Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after stroke: relationships with nerve growth factor., PMID:14973226

Target validation in drug discovery., PMID:16988416

[Preparation and detection of phosphorylated PRAS40 (Ser183) polyclonal antibody]., PMID:19835147

Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors., PMID:20686178

Accelerated tumor growth mediated by sublytic levels of antibody-induced complement activation is associated with activation of the PI3K/AKT survival pathway., PMID:23833306

Down-regulation of phosphoglucose isomerase/autocrine motility factor enhances gensenoside Rh2 pharmacological action on leukemia KG1α cells., PMID:24606425

mTOR activity in AIDS-related diffuse large B-cell lymphoma., PMID:28192480

Quantitative proteomics profiling reveals activation of mTOR pathway in trastuzumab resistance., PMID:28507275

Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma., PMID:30129426

Bloom Syndrome Protein Activates AKT and PRAS40 in Prostate Cancer Cells., PMID:31210839

Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine., PMID:33212364

Targeting PRAS40: a novel therapeutic strategy for human diseases., PMID:33504218

PCR Array Technology in Biopsy Samples Identifies Up-Regulated mTOR Pathway Genes as Potential Rejection Biomarkers After Kidney Transplantation., PMID:33681239

Autophagy and intracellular product degradation genes identified by systems biology analysis reduce aggregation of bispecific antibody in CHO cells., PMID:35123066

Datasheet

Document Download

Anti-AKT1S1 Antibody (R2T04).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-AKT1S1 Antibody (R2T04) [RHN89401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2026 AntibodySystem All Rights Reserved.            All Products are for Research Use Only